Omined-DSR Capsule is a fixed-dose combination medication containing Domperidone 30 mg and Esomeprazole 40 mg, indicated for the management of gastroesophageal reflux disease (GERD), dyspepsia, and related upper gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the tone of the lower esophageal sphincter and accelerating gastric emptying, thereby reducing symptoms such as nausea, vomiting, and bloating. Esomeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme in the gastric parietal cells, promoting mucosal healing and symptom relief in acid-related conditions. The combination offers a dual mechanism of action, providing symptomatic relief from acid reflux and improving gastric motility, which enhances patient compliance and therapeutic efficacy. Omimed-DSR is typically administered orally once daily before meals, with dosage adjustments based on clinical response and tolerability. It is contraindicated in patients with known hypersensitivity to either component, and caution is advised in individuals with hepatic impairment or cardiac arrhythmias. Common adverse effects may include headache, dry mouth, and abdominal discomfort. Consultation with a healthcare professional is recommended prior to initiation to ensure appropriate use and monitoring.